ALOGLIPTIN\METFORMIN: 372 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
372
Total FAERS Reports
27 (7.3%)
Deaths Reported
143
Hospitalizations
372
As Primary/Secondary Suspect
19
Life-Threatening
10
Disabilities
Active Ingredient: ALOGLIPTIN BENZOATE\METFORMIN HYDROCHLORIDE ·
First Report: 2013 · Latest Report: 20241229
What Are the Most Common ALOGLIPTIN\METFORMIN Side Effects?
#1 Most Reported
Off label use
35 reports (9.4%)
#2 Most Reported
Diarrhoea
34 reports (9.1%)
#3 Most Reported
Pneumonia
24 reports (6.5%)
All ALOGLIPTIN\METFORMIN Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 35 | 9.4% | 3 | 21 |
| Diarrhoea | 34 | 9.1% | 0 | 20 |
| Pneumonia | 24 | 6.5% | 2 | 4 |
| Pemphigoid | 19 | 5.1% | 0 | 7 |
| Disease recurrence | 18 | 4.8% | 0 | 0 |
| Drug ineffective | 17 | 4.6% | 0 | 2 |
| Hypertension | 17 | 4.6% | 0 | 0 |
| Lactic acidosis | 17 | 4.6% | 3 | 7 |
| Tonsil cancer | 16 | 4.3% | 0 | 15 |
| Blood pressure increased | 15 | 4.0% | 0 | 0 |
| Appetite disorder | 14 | 3.8% | 0 | 14 |
| Fall | 14 | 3.8% | 1 | 12 |
| Nausea | 12 | 3.2% | 0 | 0 |
| Sars-cov-2 test positive | 12 | 3.2% | 0 | 12 |
| Anxiety | 11 | 3.0% | 0 | 0 |
| Malaise | 11 | 3.0% | 0 | 4 |
| Poor venous access | 11 | 3.0% | 0 | 0 |
| Product use issue | 11 | 3.0% | 0 | 11 |
| Death | 10 | 2.7% | 10 | 3 |
| Dyspnoea | 10 | 2.7% | 0 | 2 |
Who Reports ALOGLIPTIN\METFORMIN Side Effects? Age & Gender Data
Gender: 42.0% female, 58.0% male. Average age: 67.2 years. Most reports from: JP. View detailed demographics →
Is ALOGLIPTIN\METFORMIN Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2013 | 7 | 0 | 0 |
| 2014 | 12 | 0 | 2 |
| 2015 | 6 | 0 | 3 |
| 2016 | 14 | 0 | 6 |
| 2017 | 17 | 1 | 8 |
| 2018 | 64 | 11 | 31 |
| 2019 | 27 | 4 | 17 |
| 2020 | 23 | 2 | 15 |
| 2021 | 18 | 0 | 6 |
| 2022 | 7 | 1 | 1 |
| 2023 | 7 | 0 | 2 |
| 2024 | 3 | 0 | 2 |
What Is ALOGLIPTIN\METFORMIN Used For?
| Indication | Reports |
|---|---|
| Type 2 diabetes mellitus | 130 |
| Diabetes mellitus | 116 |
| Product used for unknown indication | 101 |
| Blood glucose abnormal | 6 |
ALOGLIPTIN\METFORMIN vs Alternatives: Which Is Safer?
ALOGLIPTIN\METFORMIN vs ALOGLIPTIN\PIOGLITAZONE
ALOGLIPTIN\METFORMIN vs ALOSETRON
ALOGLIPTIN\METFORMIN vs ALPELISIB
ALOGLIPTIN\METFORMIN vs ALPHA.-LIPOIC ACID
ALOGLIPTIN\METFORMIN vs ALPHA.-TOCOPHEROL
ALOGLIPTIN\METFORMIN vs ALPHA.-TOCOPHEROL, D-
ALOGLIPTIN\METFORMIN vs ALPHA.-TOCOPHEROL, DL-
ALOGLIPTIN\METFORMIN vs ALPHA.1-PROTEINASE INHIBITOR HUMAN
ALOGLIPTIN\METFORMIN vs ALPRAZOLAM
ALOGLIPTIN\METFORMIN vs ALPROSTADIL
Official FDA Label for ALOGLIPTIN\METFORMIN
Official prescribing information from the FDA-approved drug label.